Friday, May 9, 2014

Seeking Alpha: Lundbeck Starting Slow, But Still Looking For The Big Finish

H Lundbeck A/S (OTCPK:HLUYY) (LUN.CO) remains in a "hurry up and wait" gray area. Key drugs like Brintellix and Abilify Maintena are only just getting started and investors are on tenterhooks waiting for Phase III data on key pipeline candidates like brexpiprazole and desmoteplase. While the shares still look undervalued today, further progression in the Brintellix launch and key pipeline updates will likely lead to significant revisions in estimated value before 2014 is over.

Read more here:
Lundbeck Starting Slow, But Still Looking For The Big Finish

No comments: